07/31/2024

The FDA Warns Some People are Overdosing on Semaglutide

The agency says people may be subject to dosing errors

The U.S. Food and Drug Administration (FDA) has issued a new warning about a popular medication used for weight loss.

The FDA says it has received reports of people overdosing on compounded semaglutide, giving themselves as much as 20 times more than the intended dose of the medication.

The incidents, some of which required hospitalization, involve semaglutide that is drawn from a vial and taken by injection, according to the FDA.

Please select this link to read the complete article from ABC News.